Table 1 Patient characteristics
Pelvic LN negative | Pelvic LN positive | |||
|---|---|---|---|---|
(n = 62) | (n = 67) | |||
Nodal boost | No nodal boost | |||
(n = 36) | (n = 31) | |||
Age | Median (years) | 67 | 56 | 56 |
Range (years) | 36 to 95 | 33 to 85 | 37 to 82 | |
Histology | SCC | 53 | 28 | 25 |
Adenocarcinoma | 6 | 4 | 3 | |
Adenosquamous | 3 | 2 | 1 | |
Small cell | 0 | 1 | 0 | |
Mucinous | 0 | 0 | 1 | |
Not available | 0 | 1 | 1 | |
FIGO stage* | IA2 | 1 | 0 | 0 |
IB1 | 8 | 5 | 2 | |
IB2 | 8 | 2 | 0 | |
IIA | 13 | 5 | 1 | |
IIB | 15 | 9 | 17 | |
IIIA | 0 | 2 | 2 | |
IIIB | 16 | 13 | 9 | |
IVA | 1 | 0 | 0 | |
LN size | Median (mm) | NA | 17 | 15 |
Range (mm) | NA | 7.7 to 38 | 10 to 27 | |